Radiat Oncol J.
2017 Jun;35(2):153-162. 10.3857/roj.2017.00094.
Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study
- Affiliations
-
- 1Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. COSUH317@yuhs.ac
- 2Department of Neurosurgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
- 3Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
- KMID: 2386213
- DOI: http://doi.org/10.3857/roj.2017.00094
Abstract
- PURPOSE
To evaluate intracranial control after surgical resection according to the adjuvant treatment received in order to assess the optimal radiotherapy (RT) dose and volume.
MATERIALS AND METHODS
Between 2003 and 2015, a total of 53 patients with brain oligometastases from non-small cell lung cancer (NSCLC) underwent metastasectomy. The patients were divided into three groups according to the adjuvant treatment received: whole brain radiotherapy (WBRT) ± boost (WBRT ± boost group, n = 26), local RT/Gamma Knife surgery (local RT group, n = 14), and the observation group (n = 13). The most commonly used dose schedule was WBRT (25 Gy in 10 fractions, equivalent dose in 2 Gy fractions [EQD2] 26.04 Gy) with tumor bed boost (15 Gy in 5 fractions, EQD2 16.25 Gy).
RESULTS
The WBRT ± boost group showed the lowest 1-year intracranial recurrence rate of 30.4%, followed by the local RT and observation groups, at 66.7%, and 76.9%, respectively (p = 0.006). In the WBRT ± boost group, there was no significant increase in the 1-year new site recurrence rate of patients receiving a lower dose of WBRT (EQD2) <27 Gy compared to that in patients receiving a higher WBRT dose (p = 0.553). The 1-year initial tumor site recurrence rate was lower in patients receiving tumor bed dose (EQD2) of ≥42.3 Gy compared to those receiving <42.3 Gy, although the difference was not significant (p = 0.347).
CONCLUSIONS
Adding WBRT after resection of brain oligometastases from NSCLC seems to enhance intracranial control. Furthermore, combining lower-dose WBRT with a tumor bed boost may be an attractive option.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Study on Dose Distribution at the Junction of (60)Co gamma-Ray and Elecron Beam in Postoperative Radiotherapy of Breast Cancer
- Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
- An 87-year-old patient with repeated oligorecurrences over six years whose disease were treated with radiotherapy alone
- Dose-Volume Analysis of Lung and Heart according to Respiration in Breast Cancer Patients Treated with Breast Conserving Surgery
- Prognostic Factors in Patients with Vrain Metastases from Non-Small Cell Lung Carcinoma
